| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Cathepsin L2 |
|---|
| Ligand | BDBM50602543 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2241117 (CHEMBL5155327) |
|---|
| IC50 | 186±n/a nM |
|---|
| Citation |  Ashhurst, AS; Tang, AH; Fajtová, P; Yoon, MC; Aggarwal, A; Bedding, MJ; Stoye, A; Beretta, L; Pwee, D; Drelich, A; Skinner, D; Li, L; Meek, TD; McKerrow, JH; Hook, V; Tseng, CT; Larance, M; Turville, S; Gerwick, WH; O'Donoghue, AJ; Payne, RJ Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L. J Med Chem65:2956-2970 (2022) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Cathepsin L2 |
|---|
| Name: | Cathepsin L2 |
|---|
| Synonyms: | CATL2 | CATL2_HUMAN | CTSL2 | CTSU | CTSV | Cathepsin U | Cathepsin V |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 37341.06 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | O60911 |
|---|
| Residue: | 334 |
|---|
| Sequence: | MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIE
LHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDW
RKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNG
GFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAV
ATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVK
NSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV
|
|
|
|---|
| BDBM50602543 |
|---|
| n/a |
|---|
| Name | BDBM50602543 |
|---|
| Synonyms: | CHEMBL4598338 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C45H60N6O6 |
|---|
| Mol. Mass. | 780.9945 |
|---|
| SMILES | COC1=CC(=O)N([C@H]1Cc1c[nH]c2ccccc12)C(=O)\C=C\[C@H](C)NC(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](C(C)C)N(C)C |r,t:2| |
|---|
| Structure | 
|
|---|
Search and Browse
